Published in J Gen Virol on December 01, 1991
A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J Virol (1993) 4.67
The genome sequence of herpes simplex virus type 2. J Virol (1998) 3.39
Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc Natl Acad Sci U S A (1994) 2.94
UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol (1994) 2.69
Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol (2004) 2.69
Determination and analysis of the complete nucleotide sequence of human herpesvirus. J Virol (1996) 2.37
ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J Virol (1994) 2.30
The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol (1998) 2.18
A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol (1996) 1.94
Identification of nuclear and nucleolar localization signals in the herpes simplex virus regulatory protein ICP27. J Virol (1995) 1.85
Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J Virol (1994) 1.83
Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. J Virol (2010) 1.71
Identification and characterization of the pseudorabies virus UL3.5 protein, which is involved in virus egress. J Virol (1996) 1.66
Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med (1995) 1.63
Structural and antigenic analysis of a truncated form of the herpes simplex virus glycoprotein gH-gL complex. J Virol (1998) 1.54
The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med (1996) 1.41
Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6. J Virol (2000) 1.41
Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures. J Virol (1995) 1.38
Complete sequence and comparative analysis of the genome of herpes B virus (Cercopithecine herpesvirus 1) from a rhesus monkey. J Virol (2003) 1.37
Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. J Virol (1995) 1.34
Long-term promoter activity during herpes simplex virus latency. J Virol (1994) 1.27
Signals that dictate nuclear, nucleolar, and cytoplasmic shuttling of the gamma(1)34.5 protein of herpes simplex virus type 1. J Virol (2002) 1.27
Herpes simplex virus glycoprotein K, but not its syncytial allele, inhibits cell-cell fusion mediated by the four fusogenic glycoproteins, gD, gB, gH, and gL. J Virol (2003) 1.26
The herpes simplex virus type 1 reactivation function lies outside the latency-associated transcript open reading frame ORF-2. J Virol (1993) 1.25
Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha. J Virol (2009) 1.22
Complex formation between the UL16 and UL21 tegument proteins of pseudorabies virus. J Virol (2005) 1.21
In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter. J Virol (1995) 1.20
Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. J Virol (1997) 1.19
B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells. J Virol (1999) 1.18
Replication of herpes simplex virus 1 depends on the gamma 134.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection. J Virol (2004) 1.08
The complete genome sequence of herpesvirus papio 2 (Cercopithecine herpesvirus 16) shows evidence of recombination events among various progenitor herpesviruses. J Virol (2006) 1.08
Identification and characterization of the UL56 gene product of herpes simplex virus type 2. J Virol (2002) 1.06
Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J Virol (1994) 1.06
Colocalization of the herpes simplex virus 1 UL4 protein with infected cell protein 22 in small, dense nuclear structures formed prior to onset of DNA synthesis. J Virol (1999) 0.96
Mutational analysis of ICP0R, a transrepressor protein created by alternative splicing of the ICP0 gene of herpes simplex virus type 1. J Virol (1996) 0.95
Identification, subviral localization, and functional characterization of the pseudorabies virus UL17 protein. J Virol (2005) 0.92
Functional complementation of UL3.5-negative pseudorabies virus by the bovine herpesvirus 1 UL3.5 homolog. J Virol (1997) 0.91
Analysis of the promoter and cis-acting elements regulating expression of herpes simplex virus type 2 latency-associated transcripts. J Virol (1995) 0.90
Bovine herpesvirus 1 U(L)3.5 interacts with bovine herpesvirus 1 alpha-transinducing factor. J Virol (2000) 0.88
The U(L)3 protein of herpes simplex virus 1 is translated predominantly from the second in-frame methionine codon and is subject to at least two posttranslational modifications. J Virol (1999) 0.87
Structure and sequence of the saimiriine herpesvirus 1 genome. Virology (2010) 0.85
Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK. Virus Res (2007) 0.85
Infectious laryngotracheitis herpesvirus expresses a related pair of unique nuclear proteins which are encoded by split genes located at the right end of the UL genome region. J Virol (1998) 0.84
cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo. J Virol (1996) 0.83
HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships. Future Virol (2012) 0.83
Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2. J Virol (2014) 0.81
Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice. Virology (2009) 0.80
An intertypic herpes simplex virus helicase-primase complex associated with a defect in neurovirulence has reduced primase activity. J Virol (1998) 0.80
Binding of HSV-1 glycoprotein K (gK) to signal peptide peptidase (SPP) is required for virus infectivity. PLoS One (2014) 0.79
A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis. Sci Rep (2015) 0.78
Inhibitors of signal peptide peptidase (SPP) affect HSV-1 infectivity in vitro and in vivo. Exp Eye Res (2014) 0.75
Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials. Front Oncol (2017) 0.75
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol (1985) 7.32
Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res (1986) 4.55
Systemic inflammation and disease progression in Alzheimer disease. Neurology (2009) 3.79
The genome sequence of herpes simplex virus type 2. J Virol (1998) 3.39
Structures of herpes simplex virus type 1 genes required for replication of virus DNA. J Virol (1988) 2.97
Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol (1995) 2.84
Identification and characterization of a novel non-infectious herpes simplex virus-related particle. J Gen Virol (1991) 2.74
Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomised community-based trial. Soc Sci Med (2005) 2.54
Isolation and characterization of herpes simplex virus type 1 mutants defective in the UL6 gene. Virology (1996) 2.26
The herpes simplex virus type 1 U(L)17 gene encodes virion tegument proteins that are required for cleavage and packaging of viral DNA. J Virol (1998) 2.20
Chronic anal fissure. Br J Surg (2004) 2.18
An analysis of the break points of structural rearrangements in man. J Med Genet (1974) 2.18
Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J Virol (2000) 2.17
Passive tube and suction drainage after elective cholecystectomy--a comparison using ultrasonography. J R Coll Surg Edinb (1992) 2.02
Parent reported home smoking bans and toddler (18-30 month) smoke exposure: a cross-sectional survey. Arch Dis Child (2005) 2.00
Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience (2002) 1.90
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene (1996) 1.89
Interventions to improve outpatient referrals from primary care to secondary care. Cochrane Database Syst Rev (2005) 1.88
Laparoscopic ventral rectopexy for internal rectal prolapse: short-term functional results. Colorectal Dis (2009) 1.84
The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J Gen Virol (1992) 1.84
Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.84
The U(L)15 gene of herpes simplex virus type 1 contains within its second exon a novel open reading frame that is translated in frame with the U(L)15 gene product. J Virol (1997) 1.80
The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun (2009) 1.76
Transanal glove port is a safe and cost-effective alternative for transanal endoscopic microsurgery. Br J Surg (2012) 1.76
Chromosome survey of a hospital for the mentally subnormal. 2. Autosome abnormalities. Clin Genet (1972) 1.70
The cross rates of growth of human mammary carcinoma. Cancer (1972) 1.69
Influence of a defunctioning stoma on leakage rates after low colorectal anastomosis and colonic J pouch-anal anastomosis. Br J Surg (1998) 1.67
Small bowel obstruction caused by a dislodged biliary stent. J R Coll Surg Edinb (1998) 1.65
Comparisons of nucleotide sequences in the genomes of the New Jersey and Indiana serotypes of vesicular stomatitis virus. J Virol (1980) 1.61
Microbial monitoring of the hospital environment: why and how? J Hosp Infect (2012) 1.60
Urological and colorectal complications following surgery for rectovaginal endometriosis. BJOG (2007) 1.58
The impact of re-engineering and other cost reduction strategies on the staff of a large teaching hospital: a longitudinal study. Med Care (1999) 1.57
A critical appraisal of endorectal ultrasound and transanal endoscopic microsurgery and decision-making in early rectal cancer. Colorectal Dis (2012) 1.57
DNA sequence of the region in the genome of herpes simplex virus type 1 containing the exonuclease gene and neighbouring genes. Nucleic Acids Res (1986) 1.56
Laparoscopic ventral rectopexy for external rectal prolapse improves constipation and avoids de novo constipation. Colorectal Dis (2009) 1.55
Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology (2011) 1.48
Venous thromboembolism prophylaxis used by consultant general surgeons in Scotland. J R Coll Surg Edinb (2001) 1.47
The myristylated virion proteins of herpes simplex virus type 1: investigation of their role in the virus life cycle. J Gen Virol (1992) 1.47
Sequence of 200 nucleotides at the 3'-terminus of the genome RNA of vesicular stomatitis virus. Nucleic Acids Res (1979) 1.46
Immunoprophylaxis in fish by injection of mouse antibody genes. Nat Biotechnol (2000) 1.44
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Ther (2001) 1.42
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Hearing loss and treatment in young Down's syndrome children. Child Care Health Dev (1982) 1.42
Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes. J Gen Virol (1990) 1.40
Hepatitis A transmission by factor IX concentrates. Vox Sang (1996) 1.40
Dear Editor. Dent Update (2016) 1.39
Pejorative statement. Br Dent J (2013) 1.39
Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci (2005) 1.37
Enhanced mutability associated with a temperature-sensitive mutant of vesicular stomatitis virus. J Virol (1981) 1.36
Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-alpha activation of SAPK in melanoma cells. J Biol Chem (1997) 1.36
The diagnosis of delayed post-operative endophthalmitis by polymerase chain reaction of bacterial DNA in vitreous samples. J Med Microbiol (1994) 1.35
The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43. J Virol (1997) 1.35
Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav Immun (2007) 1.34
Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J Virol (1990) 1.34
Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum (2004) 1.32
The management and outcome of anastomotic leaks in colorectal surgery. Colorectal Dis (2007) 1.32
Immunodiffusion analysis shows that Mycobacterium paratuberculosis and other mycobactin-dependent mycobacteria are variants of Mycobacterium avium. J Appl Bacteriol (1986) 1.28
Laparoscopic ventral rectopexy for external rectal prolapse is safe and effective in the elderly. Does this make perineal procedures obsolete? Colorectal Dis (2011) 1.28
Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology (1996) 1.27
Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci (2005) 1.24
Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry (1997) 1.22
Three-year prognosis of depression in the community-dwelling elderly. Br J Psychiatry (2000) 1.17
A novel herpes simplex virus gene (UL49A) encodes a putative membrane protein with counterparts in other herpesviruses. J Gen Virol (1992) 1.13
Effect of bases contiguous to AUG on translation initiation. J Biol Chem (1982) 1.12
Risk behaviour, healthcare access and prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoeae in a population-based sample of adults in Barbados. Sex Transm Infect (2008) 1.11
Farm exposure in utero may protect against asthma, hay fever and eczema. Eur Respir J (2008) 1.11
Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab (2014) 1.07
Isolation and point of action of a factor from Escherichia coli required to reconstruct translation. Proc Natl Acad Sci U S A (1985) 1.06
Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity. Biochem Pharmacol (1984) 1.03
MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease. Neurobiol Dis (2005) 1.03
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators. J Infect Dis (2000) 1.01
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. J Infect Dis (2001) 1.01
Vital signs for children at triage: a multicentre validation of the revised South African Triage Scale (SATS) for children. S Afr Med J (2013) 1.00
Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. Mol Immunol (1994) 1.00
The long-term results of percutaneous drainage of diverticular abscess. Ann R Coll Surg Engl (2008) 1.00
Hepatitis B virus precore/core variation and interferon therapy. Hepatology (1995) 0.99
Molecular cloning of interleukin 1beta from rainbow trout Oncorhynchus mykiss reveals no evidence of an ice cut site. Cytokine (1999) 0.99
Performance of young people with Down syndrome on the Leiter-R and British picture vocabulary scales. J Intellect Disabil Res (2005) 0.98
What are the symptoms of internal rectal prolapse? Colorectal Dis (2013) 0.98
Characterization of the protein encoded by gene UL49A of herpes simplex virus type 1. J Gen Virol (1998) 0.98
N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut (1997) 0.97
When are the hands of healthcare workers positive for methicillin-resistant Staphylococcus aureus? J Hosp Infect (2010) 0.95
Oral ciprofloxacin therapy for infections in cancer patients. J Antimicrob Chemother (1989) 0.95
The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides. Biochemistry (1991) 0.95
Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J Neuropathol Exp Neurol (2000) 0.94
Isolation of the first piscine transforming growth factor beta gene: analysis reveals tissue specific expression and a potential regulatory sequence in rainbow trout (Oncorhynchus mykiss). Cytokine (1998) 0.94
Musculoskeletal disorders among Irish farmers. Occup Med (Lond) (2010) 0.94
Christ's Hospital: infant and child mortality in the sixteenth century. Local Popul Stud (1977) 0.94
Factors related to stress and satisfaction with life in families of children with Down's syndrome. J Child Psychol Psychiatry (1991) 0.94
Long-term functional outcome after low anterior resection: comparison of low colorectal anastomosis and colonic J-pouch-anal anastomosis. Dis Colon Rectum (1998) 0.94
Local recurrence after stenting for obstructing left-sided colonic cancer. Br J Surg (2013) 0.93
Directional limits on persistent gravitational waves using LIGO S5 science data. Phys Rev Lett (2011) 0.93
Rethinking public health: new training for new times. J Manag Med (1999) 0.93
Laparoscopic ventral rectopexy for faecal incontinence: equivalent benefit is seen in internal and external rectal prolapse. J Gastrointest Surg (2014) 0.92
Intravenous ciprofloxacin for infections in cancer patients. Am J Med (1989) 0.92